Founded in 2014, Canopy Growth is a world-leading diversified cannabis and hemp company, providing cannabis products for medical and recreational use in dried, oil and Softgel capsule forms.

Canopy Growth runs 10 licensed cannabis production sites with over 2.4 million square feet of production capacity and has operations in 9 countries across 5 continents.

Impressive partnerships with leading sector names including cannabis icon DNA Genetics, Green House seeds, and Fortune 500 alcohol leader Constellation Brands.

With the market in Canada gearing up to fully legalized recreational cannabis use in August this year, management recognized the need to raise funds to capitalize on their current 28% market share to allow for future expansion and growth.

Canopy Growth is listed on the Toronto Stock Exchange (WEED CN) and the New York Stock Exchange (CGC US).


About Canopy Growth Corporation

Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

Discover Canopy Growth Corporation

Olivier Garnier

Investment Banking

Olivier Garnier photo

Charles Tellier

Investment Banking

Pierre Sertour

Investment Banking

Pierre Sertour photo

Pierre Kiecolt-Wahl

Equity Capital Markets

Pierre Kiecolt-Wahl photo

Jean de Pracomtal

Investment Banking

Jean de Pracomtal photo

Deal Team

Should you want to know more about this transaction, you can contact one of the team members above

Privacy Preference Center

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }